The manufacturer claimed that there was not sufficient data to establish a causal connection between the use of a GLP-1 receptor agonist (semaglutide) and NAION
It was found that semaglutide, a long-acting GLP-1RA, could improve symptoms caused by sepsis, reduce body temperature, and decrease the bacterial load in multiple organs, along with the levels of inflammatory factors in plasma and lungs
Why it's included Included for its supportive role in metabolic function and its potential to help ease nausea, which can occur with GLP-1 therapies
Common examples include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro), which is a dual GLP-1 and GIP receptor agonist
They require expert guidance.